CVD Risk Estimator Plus vs ATA Calculator

This clinical decision-support app is intended for use by healthcare professionals and unifies two cardiovascular prevention tools: the 2013 ACC/AHA Pooled Cohort Equations (previously known as the ASCVD Risk Estimator) and the American Heart Association’s PREVENT™ Calculator. Combining traditional ASCVD risk modeling with modern cardiovascular-kidney-metabolic (CKM)-inclusive risk equations, CVD Risk Estimator Plus supports comprehensive, personalized cardiovascular disease (CVD) risk assessment and clinician-guided decision-making. The results and recommendations provided by this application are intended to inform but do not replace clinical judgment. Therapeutic options should be individualized and determined after discussion between the patient and their care provider. CVD Risk Estimator Plus computes risk estimates using: • 2013 ASCVD Pooled Cohort Equations (PCE), which calculate 10-year and lifetime risk of atherosclerotic cardiovascular disease using age, sex, race, blood pressure, cholesterol profile, diabetes status, and smoking status. • 2023 PREVENT™ Equations, which estimate 10- and 30-year risk for total CVD, ASCVD, and heart failure (HF), incorporating kidney and metabolic health measures such as BMI and estimated glomerular filtration rate (eGFR), and supporting optional predictors including urine albumin creatinine ratio (UACR), hemoglobin A1c (HbA1c), and social deprivation index (SDI). Clinicians can toggle between Pooled Cohort and PREVENT™ risk trajectories to support guideline-aligned prevention discussions. This clinical decision support app provides: • Risk category classification (low, borderline, intermediate, high). • Personalized guidance informed by published guidelines, including statin therapy considerations, lifestyle interventions, and risk-enhancing clinical factors. • Export functionality supporting print and email of results for documentation and patient communication. • Resources page with related tools and informational materials for clinicians and patients, including links to source guidelines and reference documents.

The American Thyroid Association has developed thyroid nodule calculators to provide guidance and recommendations for particular practice areas concerning thyroid disease and thyroid cancer. The Calculators are not inclusive of all proper approaches or methods, or exclusive of others. The Calculators do not establish a standard of care and specific outcomes are not guaranteed. Treatment decisions must be made based on the independent judgment of health care providers and each patient’s individual circumstances. A calculator is not intended to take the place of physician judgment in diagnosing and treatment of particular patients. The ATA calculators are based on the evidence available in the literature and the expert opinion of ATA members in the recent timeframe of the development of calculators. Management issues have not been and cannot be comprehensively addressed in randomized trials; therefore, the evidence cannot be comprehensive. Calculators cannot always account for individual variation among patients. Calculators cannot be considered inclusive of all proper methods of care or exclusive of other treatments reasonably directed at obtaining the same results. Therefore, the American Thyroid Association considers adherence to these calculations to be voluntary, with the ultimate determination regarding its application to be made by the treating physician and health care professionals with the full consideration of the individual patient’s clinical history and physical status. In addition, the calculator concerns the therapeutic interventions used in clinical practice and do not pertain to clinical trials. Clinical trials are a separate matter, designed to research new and novel therapies, and the calculators are not necessarily relevant to their purpose.